Aurobindo Pharma gets VAI classification from USFDA for Hyderabad unit

As per the USFDA, a VAI inspection classification indicates that although investigators found and documented objectionable conditions during the inspection, FDA will not take or recommend regulatory or enforcement action because the objectionable conditions do not meet the threshold for action at this time.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news